Disclosures for "Pre-diagnosis Predictors of High Health Care Cost Among Patients with Myasthenia Gravis Using a Combined Machine-learning and Regression Approach"
-
Ms. Zhdanava has received personal compensation for serving as an employee of Analysis Group.
-
Dr. Pesa has received personal compensation for serving as an employee of Janssen. Dr. Pesa has stock in J&J.
-
Dr. Boonmak has received personal compensation for serving as an employee of Analysis Group, Inc.
-
Mr. Schwartzbein has received personal compensation for serving as an employee of Analysis Group.
-
Ms. Cai has received stock or an ownership interest from J&J.
-
Mr. Pilon has received personal compensation for serving as an employee of Analysis Group, Inc..
-
Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
-
Marie-Helene Lafeuille has nothing to disclose.
-
The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acadia Pharmaceuticals. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for GSK. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Janssen Scientific Affairs. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Novartis. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Otsuka. The institution of Patrick Lefebvre has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Pharmacyclics. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Regeneron.
-
Dr. Souayah has received publishing royalties from a publication relating to health care.